Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : PCI Biotech
Deal Size : Undisclosed
Deal Type : Collaboration
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Details : The project is the first step in determining if there is a basis for a further collaboration between Mymetics and PCI Biotech, of short duration and without immediate commercial impact for either of the parties involved.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 31, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : PCI Biotech
Deal Size : Undisclosed
Deal Type : Collaboration